Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice

Alessia Mirra, Simona Rossi, Silvia Scaricamazza, Michela DI Salvio, Illari Salvatori, Cristiana Valle, Paola Rusmini, Angelo Poletti, Gianluca Cestra, Maria Teresa Carrì, Mauro Cozzolino

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.

Original languageEnglish
Article number2033
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Spinal Muscular Atrophy
Amyotrophic Lateral Sclerosis
Alternative Splicing
RNA
Small Nuclear Ribonucleoproteins
Haploinsufficiency
Motor Neurons
Transgenic Mice
Drosophila
Phenotype
Gene Expression
Genes
Proteins

ASJC Scopus subject areas

  • General

Cite this

Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice. / Mirra, Alessia; Rossi, Simona; Scaricamazza, Silvia; DI Salvio, Michela; Salvatori, Illari; Valle, Cristiana; Rusmini, Paola; Poletti, Angelo; Cestra, Gianluca; Carrì, Maria Teresa; Cozzolino, Mauro.

In: Scientific Reports, Vol. 7, No. 1, 2033, 01.12.2017.

Research output: Contribution to journalArticle

Mirra, A, Rossi, S, Scaricamazza, S, DI Salvio, M, Salvatori, I, Valle, C, Rusmini, P, Poletti, A, Cestra, G, Carrì, MT & Cozzolino, M 2017, 'Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice', Scientific Reports, vol. 7, no. 1, 2033. https://doi.org/10.1038/s41598-017-02195-0
Mirra, Alessia ; Rossi, Simona ; Scaricamazza, Silvia ; DI Salvio, Michela ; Salvatori, Illari ; Valle, Cristiana ; Rusmini, Paola ; Poletti, Angelo ; Cestra, Gianluca ; Carrì, Maria Teresa ; Cozzolino, Mauro. / Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{bf6e0863acfb40fdae7263477e810ea8,
title = "Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice",
abstract = "Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.",
author = "Alessia Mirra and Simona Rossi and Silvia Scaricamazza and {DI Salvio}, Michela and Illari Salvatori and Cristiana Valle and Paola Rusmini and Angelo Poletti and Gianluca Cestra and Carr{\`i}, {Maria Teresa} and Mauro Cozzolino",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-02195-0",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice

AU - Mirra, Alessia

AU - Rossi, Simona

AU - Scaricamazza, Silvia

AU - DI Salvio, Michela

AU - Salvatori, Illari

AU - Valle, Cristiana

AU - Rusmini, Paola

AU - Poletti, Angelo

AU - Cestra, Gianluca

AU - Carrì, Maria Teresa

AU - Cozzolino, Mauro

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.

AB - Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.

UR - http://www.scopus.com/inward/record.url?scp=85019424862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019424862&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-02195-0

DO - 10.1038/s41598-017-02195-0

M3 - Article

AN - SCOPUS:85019424862

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 2033

ER -